Scholars@Duke
Jennifer Shiunroh Li

Jennifer Shiunroh Li

Beverly C. Morgan, M.D., Distinguished Professor of Pediatric Cardiology
Pediatrics, Cardiology
li000001@mc.duke.edu
1927C Childrens Hlth Ctr, Box 3090, Durham, NC 27710
1927C Childrens Hlth Ctr, Box 3090, Durham, NC 27710

Overview

1. Pediatric hypertension and hyperlipidemia
2. Clinical trials in children with heart disease
3. Thrombosis in patients with congenital heart disease
4. Enzyme replacement in Pompe disease
5. Infective endocarditis

Current Duke Appointments & Affiliations

Beverly C. Morgan, M.D., Distinguished Professor of Pediatric Cardiology · 2012 - Present Pediatrics, Cardiology, Pediatrics
Professor of Pediatrics · 2008 - Present Pediatrics, Cardiology, Pediatrics
Professor of Medicine · 2008 - Present Medicine, Cardiology, Medicine
Member in the Duke Clinical Research Institute · 1999 - Present Duke Clinical Research Institute, Institutes and Centers

Recent News Items

Published September 16, 2022
No More Guessing on the Right Dosage for Children
Published June 1, 2021
Asking New Questions in the Fight Against Childhood Obesity
Published June 13, 2017
Duke Health Trials on Childhood Obesity Will Study Efficacy of Weight Loss Programs, Biomarkers of Obesity

View All News Items

Recent Scholarly Works

Genetic Determinants of Early Heart Failure in Hypoplastic Left Heart Syndrome: A Prospective NC-DEFINE Study.

Journal article J Am Coll Cardiol · September 8, 2026 BACKGROUND: Survivors of hypoplastic left heart syndrome (HLHS), the most severe form of congenital heart disease, are at high risk for heart failure (HF). HF in early life is a major contributor to mortality in this vulnerable population. However, reliabl ... Full text Link to item Cite

Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event.

Journal article N Engl J Med · August 29, 2026 BACKGROUND: Patients are at increased risk for recurrent ischemic events after an acute coronary syndrome event. Milvexian, an oral factor XIa inhibitor, may reduce the risk of major adverse clinical events with minimal bleeding risk. METHODS: In this phas ... Full text Link to item Cite

Health Care Utilization in Adults With Congenital Heart Disease: Population-Based Findings.

Journal article Birth Defects Res · June 2026 BACKGROUND: Population-based data on healthcare utilization in adults with congenital heart disease (CHD) are limited. We examined utilization patterns in a multi-site, population-based U.S. cohort of adults with CHD. METHODS: This retrospective cohort lin ... Full text Link to item Cite
View All Scholarly Works

Recent Grants

1/3 CTSA UM1 at Duke University

ResearchCore Leader · Awarded by National Center for Advancing Translational Sciences · 2025 - 2032

Machine learning-enhanced cardiomyopathy prediction in childhood cancer survivors

ResearchCo-Mentor · Awarded by National Institutes of Health · 2026 - 2031

iPediHeart: Interdisciplinary Research Training Program for Pediatric Heart Disease

Inst. Training Prgm or CMEPrincipal Investigator · Awarded by National Heart, Lung, and Blood Institute · 2025 - 2030

View All Grants

Education

Duke University · 1987 M.D.